<DOC>
	<DOCNO>NCT02996240</DOCNO>
	<brief_summary>Assess impact dietary omega 3 free fatty acid breast cancer patient .</brief_summary>
	<brief_title>Breast , Omega 3 Free Fatty Acid , Ph 0</brief_title>
	<detailed_description>Prospective , single arm , short term study correlative biomarker endpoint . Two hundred ( 200 ) newly diagnose breast cancer patient recruit participate short term ( 30 day ) Phase 0 biomarker evaluation study prior surgical resection . Patients receive fish Oil ( Omega-3 FFAs , 2700 mg mouth twice daily ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>At least 18 year age ECOG â‰¤2 Ability understand purpose risk study sign write informed consent form approve investigator 's IRB/Ethics Committee Consented tissue collection CTRC repository 0732 Active systemic illness ( infection include viral illness Hepatitis HIV ) Chronic use NSAIDs omega3 free fatty acid supplementation within last 60 day ( defined great equal 7 consecutive day ) Any NSAIDs omega3 free fatty acid supplementation within last 14 day History medical noncompliance Scheduled date surgical resection would limit amount time take intervention le 21 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>